Very interesting trio I see involved in upcoming Nov presentation ...and one should be very curious of the timing of Precision for Medicine advised by Bird/Bird to buy out Epiontis so the trio becomes a duo....and my question of late to all...
The new knowledge learned that was once for hundreds of years non-obvious....but then when PS Targeting collaborations make one smarter and realize what was once non obvious but after PS Targeting ....is absolutely obvious, THEN patents filed based on that knowledge AFTER PS Targeting Biomarkers are discovered ....should be claimed by Peregrine for IP rights....
....but what about companies bought out due to this knowledge ?? Things become more interesting now and why did Bird/Bird advise Precision for Medicine to buy Epiontis? ...when the trio were in collaborations / research....